We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-6.73%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$4.47B
AUM Growth
-$295M
Cap. Flow
-$1.59B
Cap. Flow %
-35.66%
Top 10 Hldgs %
41.85%
Holding
141
New
13
Increased
10
Reduced
16
Closed
19

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$48.9M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$45.3M
3
LUNG icon
Pulmonx
LUNG
+$34.3M
4
AHCO icon
AdaptHealth
AHCO
+$25.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$23.7M

Top Sells

Rank Stock Value
1
APR
Apria, Inc. Common Stock
APR
+$54M
2
GKOS icon
Glaukos
GKOS
+$41.9M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$40.1M
4
CNC icon
Centene
CNC
+$36.9M
5
PCRX icon
Pacira BioSciences
PCRX
+$35.9M

Sector Composition

Rank Sector Weight
1 Healthcare 54.44%
2 Financials 1.5%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TOIIW
76
The Oncology Institute Warrant
TOIIW
$1.44M 0.03%
1,250,000
– –
CMAXW
77
DELISTED
CareMax, Inc. Warrant
CMAXW
$1.28M 0.03%
672,000
– –
MDVL
78
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$1.11M 0.02%
22,851
– –
CABA icon
79
Cabaletta Bio
CABA
$444M
$942K 0.02%
464,252
– –
ROIVW
80
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$880K 0.02%
1,000,000
– –
BFLY.WS
81
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$748K 0.02%
733,333
– –
QSIAW
82
DELISTED
Quantum-Si Inc Warrant
QSIAW
$383K 0.01%
333,333
– –
SLGCW
83
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$257K 0.01%
120,000
– –
NUVB.WS
84
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$135K ﹤0.01%
166,666
– –
PKBOW
85
DELISTED
Peak Bio, Inc. Warrant
PKBOW
$132K ﹤0.01%
362,500
– –
SRSAW
86
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$120K ﹤0.01%
+333,333
New +$205K
SNRHW
87
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$90K ﹤0.01%
500,000
– –
REVHW
88
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$90K ﹤0.01%
200,000
– –
TLSIW icon
89
TriSalus Life Sciences Warrant
TLSIW
$25.5M
$85K ﹤0.01%
333,333
– –
TMPMW
90
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$82K ﹤0.01%
250,000
– –
EUCRW
91
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$62K ﹤0.01%
333,333
– –
SRZNW icon
92
Surrozen Inc Warrant
SRZNW
$75.6K
$42K ﹤0.01%
166,666
– –
OHPAW
93
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$39K ﹤0.01%
125,000
– –
WINT
94
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
PMVP icon
95
PMV Pharmaceuticals
PMVP
$62.9M
$10K ﹤0.01%
470
-521,530
-100% -$9.2M
APLS
96
DELISTED
Apellis Pharmaceuticals
APLS
– –
-343,213
Closed -$16.2M
BBIO icon
97
CALL
BridgeBio Pharma
BBIO
$16.5B
– –
-1,000,000
Closed -$16.7M
BPMC
98
DELISTED
Blueprint Medicines
BPMC
– –
-110,000
Closed -$11.8M
DH icon
99
Definitive Healthcare
DH
$71.1M
– –
-250,000
Closed -$6.83M
ESPR
100
DELISTED
Esperion Therapeutics
ESPR
– –
-5,000,000
Closed -$25M
1 2 3
4
5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2022 Portfolio in Review

As of Q1 2022, Deerfield Management held 141 positions worth $4.47B, down 6.2% from $4.77B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Deerfield Management withdrew a net $1.59B in Q1 2022, closing 19 positions and reducing 16 holdings. Its most notable exit was Apria, Inc. Common Stock, an estimated $54M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 63% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Deerfield Management opened a new position in Gilead Sciences worth $45.5M.

  • Deerfield Management's largest Q1 2022 buy was Gilead Sciences: 765,489 shares worth $45.5M.
  • Deerfield Management added most to Pulmonx in Q1 2022, an estimated $34.3M increase.
  • Deerfield Management's biggest Q1 2022 reduction was Glaukos, cutting an estimated $41.9M.
  • Deerfield Management fully exited Apria, Inc. Common Stock in Q1 2022, selling an estimated $54M.
  • Deerfield Management's ten largest holdings make up 42% of its $4.47B portfolio in Q1 2022.
  • Deerfield Management opened 13 new positions and closed 19 in Q1 2022.
  • Deerfield Management's portfolio value fell 6.2% quarter-over-quarter to $4.47B.

Based on Deerfield Management's 13F filing for Q1 2022, filed 16 May 2022.